Rankings
▼
Calendar
ANNX Q1 2024 Earnings — Annexon, Inc. Revenue & Financial Results | Market Cap Arena
ANNX
Annexon, Inc.
$713M
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$29M
Net Income
-$25M
EPS (Diluted)
$-0.21
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$28M
Free Cash Flow
-$28M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$304M
Total Liabilities
$42M
Stockholders' Equity
$262M
Cash & Equivalents
$152M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$29M
-$41M
+30.7%
Net Income
-$25M
-$39M
+34.9%
← FY 2024
All Quarters
Q2 2024 →